Over the past 12 months, 8 insiders at Jazz Pharmaceuticals plc filed 44 open-market SEC Form 4 transactions on JAZZ: 0 purchases worth $0 and 44 sales worth $42.0M. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Bruce C Cozadd | SELL | 6.0K | $240.47 | $1.4M |
| Jun 10, 26 | Neena M PatilEVP & Chief Legal Officer | SELL | 1.2K | $231.83 | $278K |
| Jun 1, 26 | Bruce C Cozadd | SELL | 6.0K | $235.12 | $1.4M |
| May 28, 26 | Neena M PatilEVP & Chief Legal Officer | SELL | 1.2K | $236.97 | $282K |
| May 1, 26 | Bruce C Cozadd | SELL | 6.0K | $203.33 | $1.2M |
| Mar 9, 26 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.3K | $182.94 | $235K |
| Mar 3, 26 | Bruce C CozaddDirector | SELL | 3.2K | $187.84 | $588K |
| Feb 27, 26 | Norbert G RiedelDirector | SELL | 3.4K | $192.00 | $656K |
| Feb 27, 26 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.1K | $190.91 | $213K |
| Feb 26, 26 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.3K | $194.11 | $243K |
| Feb 26, 26 | Mary Elizabeth HendersonSVP, Technical Operations | SELL | 5.3K | $194.49 | $1.0M |
| Feb 26, 26 | Neena M PatilEVP & Chief Legal Officer | SELL | 16.6K | $193.60 | $3.2M |
| Dec 9, 25 | Mary Elizabeth HendersonSVP, Technical Operations | SELL | 2.2K | $169.51 | $379K |
| Dec 5, 25 | Patricia CarrSVP, Chief Accounting Officer | SELL | 4.5K | $171.20 | $770K |
| Nov 26, 25 | Bruce C CozaddDirector | SELL | 38.1K | $179.79 | $6.8M |
| Nov 20, 25 | Heather Ann McSharryDirector | SELL | 3.4K | $177.78 | $607K |
| Nov 18, 25 | Bruce C CozaddDirector | SELL | 8.4K | $182.60 | $1.5M |
| Nov 18, 25 | Patricia CarrSVP, Chief Accounting Officer | SELL | 5.3K | $182.07 | $956K |
| Nov 18, 25 | Rick E WinninghamDirector | SELL | 5.5K | $180.86 | $995K |
| Nov 17, 25 | Robert IannoneEVP, Global Head of R&D & CMO | SELL | 7.2K | $168.26 | $1.2M |
| Oct 3, 25 | Bruce C CozaddDirector | SELL | 3.5K | $140.00 | $490K |
| Oct 1, 25 | Bruce C CozaddDirector | SELL | 2.0K | $131.78 | $264K |
| Sep 2, 25 | Bruce C CozaddDirector | SELL | 3.0K | $130.00 | $390K |
| Aug 1, 25 | Bruce C CozaddChairman & CEO | SELL | 1.0K | $113.21 | $113K |
| Jul 1, 25 | Bruce C CozaddChairman & CEO | SELL | 500 | $110.00 | $55K |
| Jun 3, 25 | Bruce C CozaddChairman & CEO | SELL | 500 | $110.00 | $55K |
| Jun 2, 25 | Bruce C CozaddChairman & CEO | SELL | 500 | $107.90 | $54K |
| May 12, 25 | Seamus MulliganDirector | BUY | 1.6K | $103.00 | $167K |
| May 9, 25 | Seamus MulliganDirector | BUY | 80.7K | $99.71 | $7.9M |
| May 2, 25 | Bruce C CozaddChairman & CEO | SELL | 500 | $120.00 | $60K |
| May 1, 25 | Bruce C CozaddChairman & CEO | SELL | 1.0K | $116.35 | $116K |
| Apr 1, 25 | Bruce C CozaddChairman & CEO | SELL | 1.5K | $123.75 | $186K |
| Mar 10, 25 | Robert IannoneEVP, Global Head of R&D & CMO | SELL | 2.4K | $138.41 | $333K |
| Mar 10, 25 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.1K | $137.81 | $157K |
| Mar 7, 25 | Robert IannoneEVP, Global Head of R&D & CMO | SELL | 5.5K | $140.00 | $765K |
| Mar 3, 25 | Bruce C CozaddChairman & CEO | SELL | 6.5K | $144.25 | $938K |
| Feb 28, 25 | Patricia CarrSVP, Chief Accounting Officer | SELL | 773 | $143.30 | $111K |
| Feb 27, 25 | Patricia CarrSVP, Chief Accounting Officer | SELL | 4.5K | $144.42 | $650K |
| Feb 27, 25 | Neena M PatilEVP & Chief Legal Officer | SELL | 3.8K | $144.87 | $551K |
| Feb 3, 25 | Bruce C CozaddChairman & CEO | SELL | 1.5K | $122.31 | $183K |
| Jan 2, 25 | Bruce C CozaddChairman & CEO | SELL | 1.5K | $123.43 | $185K |
| Dec 2, 24 | Bruce C CozaddChairman & CEO | SELL | 2.0K | $121.17 | $242K |
| Dec 2, 24 | Patricia CarrSVP, Chief Accounting Officer | SELL | 53 | $122.49 | $6K |
| Nov 8, 24 | Neena M PatilEVP & Chief Legal Officer | SELL | 3.7K | $123.41 | $457K |
| Nov 1, 24 | Bruce C CozaddChairman & CEO | SELL | 1.0K | $110.84 | $111K |
| Sep 6, 24 | Mary Elizabeth HendersonSVP, Technical Operations | SELL | 1.4K | $108.30 | $153K |
| Jun 7, 24 | Patricia CarrSVP, Chief Accounting Officer | SELL | 163 | $108.83 | $18K |
| May 3, 24 | Neena M PatilEVP & Chief Legal Officer | SELL | 5.0K | $109.65 | $548K |
| Mar 7, 24 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.8K | $116.98 | $207K |
| Mar 6, 24 | Patricia CarrSVP, Chief Accounting Officer | SELL | 1.2K | $120.85 | $149K |
Over the past 12 months, insiders at Jazz Pharmaceuticals plc filed 0 open-market purchases worth $0 and 44 sales worth $42.0M on JAZZ, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
The largest recent open-market JAZZ insider purchase in our data was $7.9M by Seamus Mulligan, Director, filed on May 9, 25.
8 different insiders at Jazz Pharmaceuticals plc filed open-market SEC Form 4 transactions on JAZZ over the last 12 months.
InsiderTape plots every JAZZ insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Jazz Pharmaceuticals plc insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →